News Agency
Men's Weekly

Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial

  • Written by Media Outreach
  • French regulator, ANSM, as well as Ethics Committee, CPP, have cleared ABX464 for Phase 2b/3 "miR-AGE" testing
  • The anti-inflammatory mechanism of action could prevent and treat cytokine storm and hyper-inflammation, which lead to acute respiratory distress syndrome (ARDS) and death of COVID-19 patients
  • New data[1] show ABX464 inhibits SARS-CoV-2...

Read more: Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in...

How Often Should You Visit the Dentist? Here’s What Experts Say

When it comes to having a healthy smile, perhaps the most frequently asked question is, "How frequently should I go to the dentist?" Although there's a rule of thumb that says visit the dentist every six months, the truth isn't... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion